Anavex Life Sciences Corp (AVXL)

[stealthways]

These epilepsy results are extremely positive... Now layer on a couple other factors:

1) at the microscopic neuron level all mammals neron function is identical...i.e. mice and men.. and add that ;

2) Consert pharma just recently did preclinical studies with a completely different molecule (more side affects than avxl and behind in trials) , but with the same target (sigma 1 receptor agonist) protein misfolding and their results were almost as good as AVXL. and ;

3) many early investors actually bought avxl for Epilepsy thinking it would be the slam dunk indication; and

4) The addition of Dr. French to the SAB...

5) I noticed that the Australian analyst Baranko put a $41 per share value in the AVXL non AD pipeline potential... x4 current price without AD.

If that is not compelling I do not know what is...I think you will be hearing a lot more about Epilepsy from AVXL...